PharVision Advisers’s Choice Hotels CHH Stock Holding History

PharVision Advisers’s Portfolio CHH Stock Details CHH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-3,282	Closed	-$313K	–	203
2025 Q4	$313K	Buy	3,282 +1,141	+53%	+$109K	0.16%	250
2025 Q3	$229K	Buy	+2,141	New	+$261K	0.13%	399

Other funds holding CHH

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

PharVision Advisers's CHH Position: Q1 2026 in Review

PharVision Advisers sold out of Choice Hotels (CHH) in Q1 2026, closing a stake of 3,282 shares — an estimated $313K sold.

PharVision Advisers first reported a position in CHH in Q3 2025 and held it in 2 quarters. The position peaked at $313K in Q4 2025. 328 funds tracked by Wall St. Rank hold CHH as of Q1 2026.

PharVision Advisers reported no remaining Choice Hotels position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 3,282 Choice Hotels shares in Q1 2026, an estimated $313K.
PharVision Advisers first reported a position in Choice Hotels in Q3 2025 and held it in 2 quarters.
PharVision Advisers's Choice Hotels position peaked at $313K in Q4 2025.
328 funds tracked by Wall St. Rank held Choice Hotels as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.